Duke-Margolis Current Topics

21st Century Public Health and Population Health

Duke-Margolis is developing a major, cross-cutting initiative to address—and inform—the future of public health in the United States, building on the Center’s work on the COVID-19 pandemic. Importantly, it will also seek to infuse reforms to public health institutions and policies suggested by the...

Duke-Margolis is developing a major, cross-cutting initiative to address—and inform—the future of...

Duke-Margolis is developing a major, cross-cutting initiative to address—and inform—the future of...

Accountable Care Transformation

The Duke-Margolis Institute for Health Policy, funded by the Gordon and Betty Moore Foundation, is investigating how accountable care approaches can improve care for people with serious illness, which is a next step in the Center’s work on accountable care. In partnership with Leavitt Partners, the...

The Duke-Margolis Institute for Health Policy, funded by the Gordon and Betty Moore Foundation, is...

The Duke-Margolis Institute for Health Policy, funded by the Gordon and Betty Moore Foundation, is...

Advancing Biomedical Innovation

Duke-Margolis, in partnership with FDA and a wide array of other stakeholder groups, is focused on improving the process of medical product development and regulatory review to increase the treatment options available to patients and the value that these products can introduce into the health care...

Duke-Margolis, in partnership with FDA and a wide array of other stakeholder groups, is focused on...

Duke-Margolis, in partnership with FDA and a wide array of other stakeholder groups, is focused on...

Advancing Social Needs and Health Equity

Clinical Trial Transformation

COVID-19 Response

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The Duke-Margolis Institute for Health Policy has marshalled its outstanding network of experts to respond to the crisis in real time, guiding Federal and state leaders through this extraordinarily difficult period....

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The...

The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The...

Digital Health & AI

Digital Health leverages the digitalization of health data and novel tools to empower more personalized management of health and wellness. This broad category includes mHealth, AI, health information technology (HIT), telemedicine, digital therapeutics and more.

Digital Health leverages the digitalization of health data and novel tools to empower more...

Digital Health leverages the digitalization of health data and novel tools to empower more...

Drug Pricing and Competition Policy

Novel technologies typically come to market with high list prices that fall over time, but which may still be high enough to impact patient access. Reforms that target drug pricing and competition can address affordability for patients, payers, and health care organizations to ultimately increase...

Novel technologies typically come to market with high list prices that fall over time, but which may...

Novel technologies typically come to market with high list prices that fall over time, but which may...

Drug-Resistant Infections & Antimicrobial Resistance (AMR)

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According to the Centers for Disease Control and Prevention (CDC), each year drug-resistant infections are responsible for 35,000 lives lost in the Unites States. And the rise of AMR threatens the...

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According...

Drug-resistant infections and antimicrobial resistance (AMR) are increasingly concerning. According...

Drug Supply Chain

Federal Health Care Transformation

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and research expertise to identify care delivery and payment transformation strategies that have an impact in real-world settings; cultivate stakeholder engagement; and develop quantitative and qualitative...

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and...

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and...

Food and Drug Administration

Duke-Margolis brings together external experts, the university’s leading research, education, and engagement capabilities, and the broader public to inform policymaking and the advancement of regulatory science at the U.S. Food and Drug Administration.

Duke-Margolis brings together external experts, the university’s leading research, education, and...

Duke-Margolis brings together external experts, the university’s leading research, education, and...

Future of Health

Health Equity

Duke-Margolis aims to ensure that its health policy research and leadership contribute significantly to dismantling health inequities and improving health and health care through the following ways: Drivers of health: Address the underlying causes of poor health or poor health outcomes through...

Duke-Margolis aims to ensure that its health policy research and leadership contribute significantly...

Duke-Margolis aims to ensure that its health policy research and leadership contribute significantly...

Hepatitis C Elimination

Medical Product Development and Regulatory Policy

Coverage and Payment Policy

Once a product is on the market, coverage and payment policies play a fundamental role in shaping access across different populations. Reforms which target challenges around coverage and payment for novel products can help address stakeholder concerns with reimbursing these products, and increase...

Once a product is on the market, coverage and payment policies play a fundamental role in shaping...

Once a product is on the market, coverage and payment policies play a fundamental role in shaping...

Real-World Evidence

As thought leaders in RWE, Duke-Margolis engages public and private stakeholders in this burgeoning field. Read on to find the publications, projects, news, and contact information of our real-world evidence team.

As thought leaders in RWE, Duke-Margolis engages public and private stakeholders in this burgeoning...

As thought leaders in RWE, Duke-Margolis engages public and private stakeholders in this burgeoning...

Reducing Viral Disease

Risk Adjustment

Serious Illness

Specialty Care Reform

State Health Care Transformation and Medicaid Transformation

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and research expertise to identify care delivery and payment transformation strategies that have an impact in real-world settings; cultivate stakeholder engagement; and develop quantitative and qualitative...

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and...

The mission of the Duke-Margolis health care transformation portfolio draws on Duke’s clinical and...

Value-Based Payment Consortium